CX 2018 Presentations

Please note: Some presentations may not be available as permission may not have been given.

VENOUS CONTROVERSIES - Tuesday, 24th April
Venue:   Lower Main Auditorium
Time: 08:00 - 18:00
WHETHER to intervene, WHEN to intervene, HOW to intervene: Outcomes and Follow-up
Chairing:   Alun Davies, London, United Kingdom
Moderator:   Ian Franklin, London, United Kingdom
Imaging section and diagnostics controversies
Time: 08:00 - 08:07
The future of venous imaging
Speaker:   Mark Meissner, Seattle, United States
Time: 08:07 - 08:14
Lessons learned from the VIDIO trial on selection and outcomes for stenting in CEAP 4-6 chronic venous hypertension
Speaker:   Paul Gagne, Darien, United States
Time: 08:14 - 08:21
Haemodynamics-objective assessment of venous and lymphatic function
Speaker:   Sergio Gianesini, Ferrara, Italy
Time: 08:21 - 08:33
Audience participation and discussion
Time: 08:33 - 08:40
Strain gauge plethysmography
Speaker:   Oskar Nelzen, Linköping, Sweden
Time: 08:40 - 08:47
Revalidation of transabdominal duplex criteria for the detection of iliac vein lesions
Speaker:   Laurencia Villalba, Wollongong, Australia
Time: 08:47 - 08:57
Audience participation and discussion
 
Deep venous controversies
Acute deep venous thrombosis
Time: 08:57 - 09:04
Deep vein thrombosis and post-thrombotic syndrome - a patient's perspective
Speaker:   Julie Bayley, Lincoln, United Kingdom
Time: 09:04 - 09:11
Long-term outcomes of indwelling vena cava filters
Speaker:   Eric Hager, Pittsburgh, United States
Time: 09:11 - 09:18
Accumulative multicenter data on treatment of femoral DVT with mechanical aspiration thrombectomy
Speaker:   Romaric Loffroy, Dijon, France
Time: 09:18 - 09:30
Audience participation and discussion
Time: 09:30 - 09:46
CX Debate: ATTRACT is the final word on lysis of proximal deep vein thrombosis

For the motion
Time: 09:30 - 09:38
Brian DeRubertis, Los Angeles, United States
CLICK HERE TO VIEW VIDEO

Against the motion
Time: 09:38 - 09:46
Mitchell Silver, Columbus, United States
CLICK HERE TO VIEW VIDEO

Time: 09:46 - 10:00
Audience participation, discussion and polling
 
Coffee
Time: 10:00 - 10:30
10:03-10:28 Coffee Symposium
Chronic venous disease management-a time for a change? Working towards an optimal, patient-centric pathway
Chairing:   Stephen Black, London, United Kingdom
Time: 10:03 - 10:06
A patient’s perspective in accessing care (video)
Time: 10:06 - 10:10
Case presentation - a patient with complex venous disease
Speaker:   Stephen Black, London, United Kingdom
Time: 10:10 - 10:15
Strategy, opinion and views on treating this patient
Speaker:   Erin Murphy, Charlotte, United States
Time: 10:15 - 10:20
Strategy, opinion and views on treating this patient
Speaker:   Marta Ramirez Ortega, Madrid, Spain
Time: 10:20 - 10:24
How I treated
Speaker:   Stephen Black, London, United Kingdom
Time: 10:24 - 10:28
Audience questions, key take-home messages and close
 
Deep venous controversies (continued)
Chairing:   Stephen Black, London, United Kingdom
Moderator:   Erin Murphy, Charlotte, United States
Venous stent
Time: 10:30 - 10:37
Entrapment and nutcracker syndrome
Speaker:   Alun Davies, London, United Kingdom
Time: 10:37 - 10:44
Risk of venous stenting across the inguinal ligament on occlusion of great saphenous vein
Speaker:   Houman Jalaie, Aachen, Germany
Time: 10:44 - 10:51
ACCESS PTS (Chronic post-thrombotic syndrome) study
Speaker:   Mark Garcia, Wilmington, United States
Time: 10:51 - 11:01
Audience participation and discussion
Time: 11:01 - 11:08
Analysis of morphology after stenting
Speaker:   Michael Lichtenberg, Arnsberg, Germany
Time: 11:08 - 11:15
Link between morphology of iliac veins and outcomes
Speaker:   Lowell Kabnick, New York, United States
Time: 11:15 - 11:22
The rationale for the ABRE venous stent design
Speaker:   Erin Murphy, Charlotte, United States
Time: 11:22 - 11:33
Audience participation and discussion
Time: 11:33 - 11:40
VERNACULAR trial-Venovo venous stent
Speaker:   Michael Dake, Tucson, United States
Time: 11:40 - 11:47
Five years of deep venous stenting-where next?
Speaker:   Rick de Graaf, Friedrichshafen, Germany
Time: 11:47 - 11:54
The need for a venous valve
Speaker:   Mark Meissner, Seattle, United States
Time: 11:54 - 12:05
Audience particpation and discussion
 
Venous ulcers and wound care
Time: 12:05 - 12:12
Value of nurse specialists for venous ulcer management
Speaker:   Vanessa Harvey, London, United Kingdom
Time: 12:12 - 12:19
The treatment of venous ulcers following ESCHAR
Speaker:   Keith Poskitt, Cheltenham, United Kingdom
Time: 12:19 - 12:30
Audience participation and discussion
 
Lunch
Time: 12:30 - 13:30
12:30-13:00 Lunch Symposium
What you need to know-criteria for the treatment and diagnosis of iliofemoral venous obstruction and pelvic venous incompetence
Moderator:   Kathleen Gibson, Bellevue, United States
Time: 12:32 - 12:44
Pelvic venous incompetence-diagnostic imaging and treatment guidelines
Speaker:   Neil Khilnani, New York, United States
Time: 12:44 - 12:56
Iliofemoral obstruction-diagnostic imaging and treatment guidelines
Speaker:   Stephen Black, London, United Kingdom
Time: 12:56 - 12:58
Audience discussion
 
Late breaking trials
Chairing:   Erin Murphy, Charlotte, United States
Moderator:   Ian Franklin, London, United Kingdom
Time: 13:30 - 13:50
Podium 1st: The EVRA trial
Speakers:   Manj Gohel, Cambridge, United Kingdom
Francine Heatley, London, United Kingdom
Alun Davies, London, United Kingdom
David Epstein, Granada, Spain
Time: 13:50 - 13:55
Ramifications of EVRA
Speaker:   Raghu Kolluri, Columbus, United States
Time: 13:55 - 14:15
Audience participation and discussion
 
Lymphoedema
Chairing:   Peter Mortimer, London, United Kingdom
Moderator:   Ian Franklin, London, United Kingdom
Time: 14:15 - 14:21
Changing concepts of lymphatic function
Time: 14:21 - 14:27
Hydrotherapy for lymphoedema
Speaker:   Sergio Gianesini, Ferrara, Italy
Time: 14:27 - 14:33
Surgical treatment of late-stage lymphoedema and advanced lipoedema
Speaker:   Harry Voesten, Drachten, Netherlands
Time: 14:33 - 14:43
Audience participation and discussion
 
Pelvic vein reflux
Chairing:   Kathleen Gibson, Bellevue, United States
Moderator:   Stephen Black, London, United Kingdom
WHETHER to intervene, WHEN to intervene, HOW to intervene
Time: 14:43 - 14:49
CEAP for pelvic vein disorder
Speaker:   Mark Meissner, Seattle, United States
Time: 14:49 - 14:55
Define the pelvic venous congestion symptom and intervention
Speaker:   Melvin Rosenblatt, Fairfield, United States
Time: 14:55 - 15:05
Audience participation and discussion
Time: 15:05 - 15:11
Development in evidence base for pelvic vein disorders
Speaker:   Neil Khilnani, New York, United States
Time: 15:11 - 15:17
Trial on correction of pelvic vein reflux via internal jugular vein
Speaker:   David Thompson, Manchester, United Kingdom
Time: 15:17 - 15:30
Audience participation and discussion
 
Tea
Time: 15:30 - 16:00
Superficial venous
Chairing:   Ian Franklin, London, United Kingdom
Moderator:   Lowell Kabnick, New York, United States
Time: 16:00 - 16:06
Sclerotherapy for pudendal thigh veins
Speaker:   Kathleen Gibson, Bellevue, United States
Time: 16:06 - 16:12
Randomised controlled study of EVLA and Foam in the SSV-a study from SFP (Fovelass Study)
Speaker:   Claudine Hamel-Desnos, Caen, France
Time: 16:12 - 16:18
Modern modalities for treating perforator veins
Speaker:   Olle Nelzen, Skoevde, Sweden
Time: 16:18 - 16:24
Management of recurrent below-the-knee saphenous reflux
Speaker:   David Greenstein, Harrow, United Kingdom
Time: 16:24 - 16:39
Audience participation and discussion
Time: 16:39 - 16:45
Evidence for cyanoacrylatic ablation
Speaker:   Kursat Bozkurt, Istanbul, Turkey
Time: 16:45 - 16:51
One extra drop made a difference in closure rate for endovenous cyanoacrylate treated great saphenous vein ≥8mm in diameter
Speaker:   Yiu Che Chan, Hong Kong, China
Time: 16:51 - 16:57
Cyanoacrylate adhesive for erectile dysfunction
Speaker:   Sriram Narayanan, Singapore, Singapore
Time: 16:57 - 17:03
The pros and cons of endovenous cyanoacrylate
Speaker:   Tobias Hirsch, Halle, Germany
Time: 17:03 - 17:18
Audience participation and discussion
Time: 17:18 - 17:24
Mechanochemical ablation-the current status
Speaker:   Steve Elias, Englewood, United States
Time: 17:24 - 17:30
Retrospective review of complications in 577 consecutive cases of cryolaser and cryosclerotherapy guided by augmented reality
Speaker:   Kasuo Miyake, Sao Paulo, Brazil
Time: 17:30 - 17:36
Reducing the incidence of hyperpigmentation after sclerotherapy with the use of an antithrombotic drug
Speaker:   Alejandro Jose Gonzalez Ochoa, St Loius, Mexico
Time: 17:36 - 17:42
Photodocumentation in aesthetic phlebology
Speaker:   Kasuo Miyake, Sao Paolo, Brazil
Time: 17:42 - 18:00
Audience participation and discussion